Younger Generations Are Biologically Older Than Their Parents Were at the Same Age

There's a difference between how old you are on paper and how old your body is running. Calendar age counts birthdays; biological age reads what the cells, organs, and metabolism actually look like, and two people born in the same year can land years apart on that scale.

A Nature Medicine study led by Washington University School of Medicine in St. Louis now reports that younger generations are biologically older, on average, than their parents were at the same age, and that gap tracks with a measurable increase in cancer diagnosed before 55.

The team analyzed 154,169 UK Biobank participants and measured systemic biological age using PhenoAge, a bloodwork-and-organ-marker composite that estimates how worn the body is compared with chronological age. Adults born between 1965 and 1974 scored 23% of a standard deviation higher on PhenoAge than those born between 1950 and 1954, even after adjusting for genetic risk.

Per standard deviation of biological age acceleration, the study found an 8% higher risk of early-onset solid cancer (hazard ratio 1.08, 95% CI 1.03–1.13). The effect held independent of polygenic risk for aging and for cancer, which means the biological-age signal isn't just a stand-in for inherited risk.

The cancers driving the signal were lung, gastrointestinal, and uterine tumors. The paper also points toward tissue-specific aging patterns: an accelerated immune system appears to precede earlier lung cancer, and aged fat tissue appears to precede earlier colorectal cancer, according to WashU Medicine's release on the work. Those tissue-level claims come from the institutional write-up and should be read as the lab's working hypothesis until they are cross-checked against the full paper.

The 23% s.d. generational shift is striking, but the study is observational: it cannot say what about modern life, including diet, sleep, pollutants, chronic stress, microbiome changes, or declining physical activity, is pushing biological age upward. Two people with identical PhenoAge can have very different underlying drivers, and the paper's partial validation cohort of 10,262 participants, using Klemera–Doubal and metabolomic age gap methods, broadly confirmed the direction of the effect without resolving its mechanism.

Siteman Cancer Center, the joint Barnes-Jewish Hospital and WashU Medicine program, is part of a Cancer Grand Challenges collaboration co-founded by the National Cancer Institute and Cancer Research UK, according to the WashU release. That program is now funding deeper investigation into the drivers of early-onset disease.

For now, the takeaway is narrower than the headline suggests. Biological age, as measured today, is a population-level signal that runs ahead of chronological age in more recent birth cohorts, and that signal correlates with a measurable bump in early-onset cancer risk. It is not yet a personal test, a cause, or a prescription. The next round of work will try to name what, exactly, is pulling those cohorts forward on the biological clock, and what, if anything, can be done to slow it.